Next, we used six different clinical and pathological parameters, including tumor size, necrosis, histological grade, TNM stage, lymphatic/vascular invasion, and perineural invasion to gain a better view of the effects of TRIM3 and TRIM16 through the progression breast cancer. Here, TRIM16 is linked to breast cancer.